Refining pathological evaluation of neoadjuvant therapy for adenocarcinoma of the esophagus

doi:10.3748/wjg.v19.i48.9282

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 19, Issue 48

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7209)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-3) series, Tables (1-5) series.

Item

Count

PDF

464

HTML

4511

Figures (1-3)

223

Tables (1-5)

267

Sum=5465

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1080

Download

664

Sum=1744

Dec 28, 2013 (publication date) through Jan 6, 2025

Times Cited of This Article

Times Cited (42)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Original Article

World J Gastroenterol. Dec 28, 2013; 19(48): 9282-9293
Published online Dec 28, 2013. doi: 10.3748/wjg.v19.i48.9282

Full Size Figure Download Figure

Figure 3 Kaplan-Meier curves of patients undergoing multimodal therapy (n = 136) grouped based on a combination of tumour regression grade and lymph node downstaging (P < 0. 0001). TRG: Tumour Regression Grade; LN: Lymph node.

Citation: Noble F, Nolan L, Bateman AC, Byrne JP, Kelly JJ, Bailey IS, Sharland DM, Rees CN, Iveson TJ, Underwood TJ, Bateman AR. Refining pathological evaluation of neoadjuvant therapy for adenocarcinoma of the esophagus. World J Gastroenterol 2013; 19(48): 9282-9293
URL: https://www.wjgnet.com/1007-9327/full/v19/i48/9282.htm
DOI: https://dx.doi.org/10.3748/wjg.v19.i48.9282